117 related articles for article (PubMed ID: 9575594)
21. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
22. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.
Gambaro G; Kinalska I; Oksa A; Pont'uch P; Hertlová M; Olsovsky J; Manitius J; Fedele D; Czekalski S; Perusicová J; Skrha J; Taton J; Grzeszczak W; Crepaldi G
J Am Soc Nephrol; 2002 Jun; 13(6):1615-25. PubMed ID: 12039991
[TBL] [Abstract][Full Text] [Related]
23. [Etiopathogenesis of early stages of diabetic nephropathy].
Pynka S; Czekolski S
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):830-5. PubMed ID: 2096378
[No Abstract] [Full Text] [Related]
24. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
[TBL] [Abstract][Full Text] [Related]
25. [Sulodexid and nephrotic syndrome in patients with diabetic nephropathy].
Valociková I
Vnitr Lek; 2011 May; 57(5):507-10. PubMed ID: 21695933
[TBL] [Abstract][Full Text] [Related]
26. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
Deepa PR; Varalakshmi P
Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
28. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
[TBL] [Abstract][Full Text] [Related]
29. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
[TBL] [Abstract][Full Text] [Related]
30. Glycosaminoglycans as a possible tool for micro- and macroalbuminuria in diabetic patients. A pilot study.
Sorrenti G; Grimaldi M; Canova N; Palazzini E; Melchionda N
J Int Med Res; 1997; 25(2):81-6. PubMed ID: 9100162
[TBL] [Abstract][Full Text] [Related]
31. Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
Skrha J; Perusicová J; Pont'uch P; Oksa A
Diabetes Res Clin Pract; 1997 Oct; 38(1):25-31. PubMed ID: 9347243
[TBL] [Abstract][Full Text] [Related]
32. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
33. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
[TBL] [Abstract][Full Text] [Related]
34. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
35. [The effect of sulodexide, a glycosaminoglycan, on albuminuria in diabetic patients].
Perusicová J; Skrha J
Vnitr Lek; 1997 Nov; 43(11):748-52. PubMed ID: 9650507
[TBL] [Abstract][Full Text] [Related]
36. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
37. [The role of intraglomerular hypertension and lipids in the development of diabetic nephropathy].
Shestakova MV; Neverov NI; Dedov II
Ter Arkh; 1993; 65(6):61-5. PubMed ID: 8378853
[TBL] [Abstract][Full Text] [Related]
38. No effect of unfractioned or low molecular weight heparin treatment on markers of vascular wall and hemostatic function in incipient diabetic nephropathy.
Myrup B; Jensen T; Gram J; Kluft C; Jespersen J; Deckert T
Diabetes Care; 1997 Oct; 20(10):1615-9. PubMed ID: 9314645
[TBL] [Abstract][Full Text] [Related]
39. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J
Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
[TBL] [Abstract][Full Text] [Related]
40. Diabetic nephropathy: has the time come to move beyond plasma creatinine?
Osman MM; Ahmed MH
Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
